financetom
Business
financetom
/
Business
/
DeepSeek's Janus Pro AI model beats rivals in image generation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DeepSeek's Janus Pro AI model beats rivals in image generation
Jan 27, 2025 10:14 AM

Jan 27 (Reuters) - DeepSeek's new open-source AI model

surpassed Stability AI and Microsoft ( MSFT )-backed OpenAI's

models in benchmarks for image generation, the Chinese startup

said in a technical report on Monday.

The company said its Janus-Pro-7B AI model outperformed

OpenAI's DALL-E 3 and Stability AI's Stable Diffusion in a

leaderboard ranking for image generation using text prompts.

The new model is an upgrade over Janus, which was launched

late last year and comes on the heels of DeepSeek launching a

new assistant based on the DeepSeek-V3 model, which has become

the top-rated free application on Apple's App Store in the

United States.

DeepSeek's technical report said the new model improves upon

Janus by upgrading its training processes, data quality, and

model size, resulting in better image stability and richer

details.

Janus-Pro achieved more visually appealing and stable image

outputs by adding 72 million high-quality synthetic images and

balancing them with real-world data, the report added.

The startup added that its larger model version, with up to

7 billion parameters, improved training speed and accuracy in

text-to-image generation and task comprehension.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved